Evonik Fermas s.r.o.

SlovakiaPart of Evonikevonik.com

Evonik Fermas s.r.o. operates as a biotechnology-focused subsidiary within the Evonik Group, located in the town of Slovenská Ľupča in Slovakia. This facility plays a central role in the company's expansion of its biotechnology capabilities, particularly in the area of fermentation technology.

The primary activities at the site involve the production of amino acids and other biotechnological products through advanced fermentation processes. These products are essential for applications in animal nutrition, where they support efficient feed formulations, as well as in other industrial sectors.

Owned by Evonik Industries AG, a major German multinational corporation specializing in specialty chemicals, Evonik Fermas s.r.o. benefits from the parent company's extensive research and development resources and global market presence. The group operates in numerous countries and is recognized for its innovations in sustainable chemistry and bioeconomy solutions.

In the chemical industry, Evonik holds a strong position in the animal nutrition and health segments, with biotechnology being a key growth area. The Slovenská Ľupča site enhances the company's ability to meet increasing demand for bio-based products while adhering to high standards of environmental and operational excellence.

Also known as Fermas.

Projects Evonik Fermas is involved in

chemXplore tracks 1 project involving Evonik Fermas, of which one is active.

Evonik Fermas's role on them: Operator.

1 Under Construction

1 expansion.

Expected to start operating
2026
none
2027
none
2028
1 project
2029
none
2030
none
2031
none
What moved recently
  • 14 September 2026 Evonik Fermas biotechnology expansion, Slovenská Ľupča · Under Construction · Slovakia

Licensors are recorded on this project For subscribers

Follow this project in chemXplore →

Latest news on Evonik Fermas

22 September 2026
Evonik refocuses portfolio and German sites, funds growth via Tailor Made cuts

Aligns businesses by role, assigns roles to six German sites, and shifts investment to Asia/Americas; launches growth projects in Canada and Slovakia, funded by cost cuts.

14 September 2026
Evonik starts Fermas biotechnology expansion in Slovakia

EUR 80m upgrade adds downstream fermentation capacity for complex pharma intermediates, targets completion early 2028 and about 50 new jobs; site runs on 100% green electricity.

22 April 2026
Evonik expands biotech drug-substance capacity in Slovakia

€80M expansion adds downstream fermentation for drug‑substance manufacturing, creates ~50 jobs; follows rhamnolipids plant and boosts biotech scale‑up and sustainability.

Where its projects are

By country, the most active first. active / all projects